Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients

NCT05636267 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

59

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to sponsor strategic development reprioritization.

Conditions

NSCLC

Interventions

DRUG: AK119
DRUG: AK112
DRUG: Pemetrexed
DRUG: Carboplatin

Sponsor

Akeso